CCR5 inhibition protects against kidney damage in several animal models of kidney disease, and CCR5 antagonists reduce kidney damage by lessening the deposition of mononuclear cells in an experimental glomerular nephritis model.29 This evidence concerns the gene CCR5 and kidney disorder.